| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3997803 | Surgical Oncology | 2012 | 5 Pages |
Abstract
Pseudomyxoma peritonei (PMP) arising from urachal tumors is extremely rare. To our knowledge, natural history, tumor biological behaviour, morbidity, treatment, and prognosis of PMP arising from the urachus are determined by the associated PMP. Management of urachal tumors with associated PMP should be based on aggressive locorregional therapy with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, similar to PMP arising from other origins.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Alejandra Martínez, Gwénael Ferron, Eliane Mery, Laurance Gladieff, Jean Pierre Delord, Denis Querleu,